-

Global Bioenergy Market Report 2023-2033: Viewed as a Key Pathway to Net Zero - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Global Market for Bioenergy 2023-2033" report has been added to ResearchAndMarkets.com's offering.

The Global Market for Bioenergy 2023-2033 is an essential resource for anyone involved in the energy and sustainability industries. The report provides extensive proprietary data on producers, production, demand, applications, market share, and pricing.

Bioenergy, a form of renewable energy derived from different sources of biomass, is viewed as a key pathway to net zero. Biomass is a promising alternative source for producing clean and sustainable energy and products, because of its communal availability, relatively lower price, and zero harmful emissions.

Biomass originates from microbes and vegetation and is generally classified into agriculture biomass, forestry biomass, crops, wood-based biomass, municipal and industrial waste, food waste, animal and human-generated waste.

Biomass can be transformed into biofuels through biological and thermal conversion approaches, such as pyrolysis, gasification, and combustion. Bioenergy technologies are fully commercial, proven at scale, and can deliver the full range of energy services: power, heat and transport fuel.

Report contents include:

  • Markets drivers, trends and challenges.
  • Bioenergy demand and consumption, historical and forecast to 2033.
  • Prices for bioenergy, by type 2020-2023.
  • Analysis of feedstocks including prices.
  • Market analysis including key players, end use markets, production processes, costs, production capacities, market demand for bioenergy.
  • Market segmentation analysis including:
  • Biodiesel.
  • Renewable diesel.
  • Bio-aviation oil.
  • Bio-naphtha.
  • Biomethanol.
  • Bioethanol.
  • Biobutanol.
  • Biogas/biomethane.
  • Biosyngas.
  • Bio-Hydrogen.
  • Electrofuels.
  • Algal biofuels.
  • Green ammonia.
  • Bio-oils.
  • Waste lubricant oils.
  • Chemical recycling for biofuels.
  • Biofuels from carbon capture.
  • Refuse-Derived Fuels.
  • Wood chip and pellet biofuels.
  • Production and synthesis methods.
  • Bioenergy industry developments and investments 2020-2023.
  • Profiles of 206 corporations, companies and start-ups. Companies profiled include Algenol, Apeiron Bioenergy, Biogasclean A/S, BTG Bioliquids, Byogy Renewables, Ductor, Enerkem, ENGIE, Euglena Co., Ltd., Firefly Green Fuels, FORGE Hydrocarbons Corporation, Fulcrum Bioenergy, Genecis Bioindustries, Gevo, Graforce Hydro GmbH, Hy2Gen AG, HydGene Renewables, Infinium Electrofuels, Kvasir Technologies, Mercurius Biorefining, Obeo Biogas, Opera Bioscience, Primary Ocean, Reverion, Steeper Energy, SunFire GmbH, Vertus Energy and Viridos, Inc.

Key Topics Covered:

  1. Research Methodology
  2. What Is Bioenergy?
  3. Bioenergy Industry Developments 2020-2023
  4. The Global Bioenergy Market
  5. Bioenergy Prices 2020-2023, by Type
  6. Biomass-Based Diesel
  7. Bio-Aviation Fuel
  8. Bio-Naphtha Fuels
  9. Biomethanol
  10. Bioethanol
  11. Biobutanol
  12. Biomass-Based Gas
  13. Electrofuels (E-Fuels)
  14. Algae-Derived Biofuels
  15. Green Ammonia
  16. Bio-Oils
  17. Chemical Recycling for Biofuels
  18. Biofuels from Carbon Capture

For more information about this report visit https://www.researchandmarkets.com/r/qjz8zs

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom